Similar articles

• Pegloticase and the patient with treatment-failure gout.

  Dave AJ, Kelly VM, Krishnan E. Dave AJ, et al. Expert Rev Clin Pharmacol. 2012 Sep;5(5):501-8. doi: 10.1586/ecp.12.48. Expert Rev Clin Pharmacol. 2012. PMID: 23121270
• Alternative treatment for chronic gout could relieve pain for thousands. The recently approved intravenous drug, pegloticase, may work when other treatments don't.

  [No authors listed] [No authors listed] Duke Med Health News. 2013 Jan;19(1):3. Duke Med Health News. 2013. PMID: 23762971 No abstract available.
• Reversal of chronic refractory tophaceous gout with erosions with pegloticase.

  Yeter KC, Ortiz EC, Arkfeld DG. Yeter KC, et al. Int J Rheum Dis. 2013 Jun;16(3):369-70. doi: 10.1111/1756-185X.12073. Epub 2013 May 23. Int J Rheum Dis. 2013. PMID: 23981765 No abstract available.
• Pegloticase for treating refractory chronic gout.

  George RL Jr, Sundy JS. George RL Jr, et al. Drugs Today (Barc). 2012 Jul;48(7):441-9. doi: 10.1358/dot.2012.48.7.1813475. Drugs Today (Barc). 2012. PMID: 22844655 Review.
• Pegloticase: a novel agent for treatment-refractory gout.

  Shannon JA, Cole SW. Shannon JA, et al. Ann Pharmacother. 2012 Mar;46(3):368-76. doi: 10.1345/aph.1Q593. Epub 2012 Mar 6. Ann Pharmacother. 2012. PMID: 22395256 Review.